|
1. Wilcox CM. Overview of infectious esophagitis. Gastroenterol Hepatol. 2013; 9: 517
2. Rosołowski M, Kierzkiewicz M. Etiology, diagnosis and treatment of infectious esophagitis. Prz Gastroenterol. 2013;8(6):333-7.
3. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.
4. Hoversten P, Kamboj AK, Wu TT, Katzka DA. Risk Factors, Endoscopic Features, and Clinical Outcomes of Cytomegalovirus Esophagitis Based on a 10-year Analysis at a Single Center. Clin Gastroenterol Hepatol. 2020 Mar;18(3):736-738.
5. Wang H-W, Kuo C-J, Lin W-R et al. Clinical characteristics and manifestation of herpes esophagitis. Medicine. 2016; 95: e3187.
6. Kim Y, Park K, Park D, Park J, Bang B, Lee S et al. Guideline for the abtibiotic use in acute gastroenteritis . Infect Chemother 2019 Jun;51(2): 217-243.
7. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al.Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report.Gut, 2012 (61): 646-664.
8. Gisbert JP,etal.IVConferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterol Hepatol.2016.
9. Yan et al. Optimus duration of regimens for Helicobacter pylori erradication. Cochrane Database of Systematic Reviews. 2013.
10. Guirao X, Arias J, Badía JM, García-Rodriguz JA, Mensa J, Álvarez Lerma F , et al. Recomendaciones en el tratamiento antibiótico empírico de la infeccion intrabadominal . Cir Esp 2010; 87 (2): 63-81.
11. Sartelli M, Chichorm-Mefire A, Labricciosa FM, Hadcastle T, Abu-Zidan FM, Adesunkanmi A, et al. The management of intrabadominal infections from a global perspective: 2017 WSES guideline for management of intraabominal infections. World Journal of Emergency Surgery 2017 (12) : 29.
12. Baron TH, DiMaio CJ, Wang AY, Morgan KA. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis.Gastroenterology. 2020;158 (1) :67-75.
13. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13 (4 Suppl 2):e1–15.
14. Yokoe M, Takada T, Mayumi T, Yoshida M, Isaji S, Wada K, et al. Japanese guidelines for the management of acute pancreatitis: Japanese guidelines 2015. J Hepatobiliary Pancreat Sci. 2015 (22) :405–32.
15. Leppäniemi, A., Tolonen, M., Tarasconi, A. et al. WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg 2019 Jun 13; 14: 27.
16. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrosis.J Hepatol. 2018; 69(2):406-460.
17. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recentguidelines and beyond. Gut 2012; 61:297–310.
18. Fernandez J, Bert F, Nicolas-Chanoine MH. The challenges of multi-drug-resistance in hepatology. J Hepatol 2016; 65:1043–1054.
|
